Trial
NCT05313009
Tarlox and Sotorasib in Patients With KRAS G12C Mutations
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Medical University of South Carolina
Collaborators
Rain Oncology Inc
Condition
Non-Small Cell Lung Cancer
Intervention
Sotorasib and Tarloxotinib
Why stopped
Study drug was discontinued by manufacturer for business reasons.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-12-16